Ghent University Academic Bibliography

Journal Article
A1
open access

Angiosarcoma : a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies

Huyen Thuc Tran Luong, Sofie Vercammen (UGent) , Ario de Marco, Hilde De Rooster (UGent) and Antonio Cosma

(2025) FRONTIERS IN ONCOLOGY. 15.

Journal Article
A1
open access

Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement

Darrell Green, Roelof van Ewijk, Elisa Tirtei, Dimosthenis Andreou, Fredrik Baecklund, Daniel Baumhoer, Stefan S. Bielack, Rajesh Botchu, Kjetil Boye, Bernadette Brennan, et al.

(2024) CLINICAL CANCER RESEARCH. 30(16). p.3395-3406

Add to list

Journal Article
A1
open access

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Sebastian M. Christ, Filippo Alongi, Umberto Ricardi, Marta Scorsetti, Lorenzo Livi, Panagiotis Balermpas, Yolande Lievens (UGent) , Pètra Braam, Barbara Alicja Jereczek-Fossa, Karin Stellamans, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 195.

Add to list

Journal Article
A1
open access

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

Sara M. Tolaney, Shom Goel, Jorge Nadal, Hannelore Denys (UGent) , Manuel R. Borrego, Lacey M. Litchfield, Jiangang Liu, Adams K. Appiah, Yanyun Chen and Fabrice André

(2024) CLINICAL CANCER RESEARCH. 30(1). p.39-49

Add to list

Journal Article
A1
open access

Targeted therapy and immunotherapy for heterogeneous breast cancer

Xiaolu Sun (UGent) , Kuai Liu, Shuli Lu, Weina He and Zixiu Du

(2022) CANCERS. 14(21).

Add to list

Journal Article
A1
open access

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial

Anita W. Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J. Biemond, Arjen A. van de Loosdrecht, Lotte E. van der Wagen, Mar Bellido, Michel van Gelder, Walter J. F. M. van der Velden, Dominik Selleslag, et al.

(2022) BLOOD ADVANCES. 6(4). p.1115-1125

Add to list

Journal Article
A1
open access

Estetrol-drospirenone combination oral contraceptive : a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

K. Gemzell-Danielsson, D. Apter, J. Zatik, Steven Weyers (UGent) , T. Piltonen, L. Suturina, I Apolikhina, M. Jost, M. D. Creinin and J-M Foidart

(2022) BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 129(1). p.63-71

Add to list

Journal Article
A1
open access

Dendritic cell-based immunotherapy in lung cancer

Dieter Stevens (UGent) , Joline Ingels (UGent) , Sandra Van Lint (UGent) , Bart Vandekerckhove (UGent) and Karim Vermaelen (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 11.

Add to list

Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

Jingwei Chen, Christopher Nelson, Matthew Wong, Andrew E. Tee, Pei Y. Liu, Ting La, Jamie I. Fletcher, Alvin Kamili, Chelsea Mayoh, Christoph Bartenhagen, et al.

(2021) CLINICAL CANCER RESEARCH. 27(5). p.1438-1451

Add to list

Journal Article
A1
open access

Defining oligometastatic disease from a radiation oncology perspective : an ESTRO-ASTRO consensus document

Yolande Lievens (UGent) , Matthias Guckenberger, Daniel Gomez, Morten Hoyer, Puneeth Iyengar, Isabelle Kindts, Alejandra Méndez Romero, Daan Nevens, David Palma, Catherine Park, et al.

(2020) RADIOTHERAPY AND ONCOLOGY. 148. p.157-166

Academic Bibliography

Angiosarcoma : a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies

Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

Targeted therapy and immunotherapy for heterogeneous breast cancer

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial

Estetrol-drospirenone combination oral contraceptive : a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

Dendritic cell-based immunotherapy in lung cancer

Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

Defining oligometastatic disease from a radiation oncology perspective : an ESTRO-ASTRO consensus document

Contents

Support

Contact